Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6651
Genworth Financial
GNW
$3.75B
| $1.08M | ﹤0.01% |
157,841
-1,127,820
| -88% | -$7.42M |
|
6652
CALL
Ligand Pharmaceuticals
LGND
$5.8B
| $1.08M | ﹤0.01% |
10,800
-15,300
| -59% | -$1.54M |
|
6653
PUT
Alamo Group
ALG
$1.98B
| $1.08M | ﹤0.01% |
6,000
+4,000
| +200% | +$713K |
|
6654
ProShares Short 20+ Year Treasury ETF
TBF
$105M
| $1.08M | ﹤0.01% |
48,781
+12,778
| +35% | +$289K |
|
|
TERN
6655
CALL
DELISTED
Terns Pharmaceuticals
TERN
| $1.08M | ﹤0.01% |
129,400
+65,500
| +103% | +$539K |
|
6656
LegalZoom.com
LZ
$1B
| $1.08M | ﹤0.01% |
+169,925
| New | +$1.11M |
|
6657
Invesco S&P 500 High Beta ETF
SPHB
$942M
| $1.08M | ﹤0.01% |
12,079
+3,114
| +35% | +$265K |
|
6658
PUT
TORM
TRMD
$3.17B
| $1.08M | ﹤0.01% |
31,500
-2,500
| -7% | -$91.7K |
|
6659
CALL
RUM Group Inc
RUM
$4.13B
| $1.08M | ﹤0.01% |
200,900
+19,500
| +11% | +$115K |
|
6660
CALL
Xometry
XMTR
$4.85B
| $1.08M | ﹤0.01% |
58,600
+19,300
| +49% | +$317K |
|
|
ACCD
6661
PUT
DELISTED
Accolade Inc
ACCD
| $1.08M | ﹤0.01% |
279,600
+6,900
| +3% | +$27K |
|
|
CHX
6662
PUT
DELISTED
ChampionX
CHX
| $1.08M | ﹤0.01% |
35,700
-11,100
| -24% | -$351K |
|
6663
PUT
BioCryst Pharmaceuticals
BCRX
$2.57B
| $1.08M | ﹤0.01% |
141,600
-70,500
| -33% | -$536K |
|
6664
ALPS O'Shares Global Internet Giants ETF
OGIG
$112M
| $1.08M | ﹤0.01% |
25,737
-17,306
| -40% | -$673K |
|
6665
VictoryShares Dividend Accelerator ETF
VSDA
$240M
| $1.08M | ﹤0.01% |
20,240
-16,131
| -44% | -$820K |
|
6666
PUT
United States Copper Index Fund
CPER
$737M
| $1.07M | ﹤0.01% |
37,900
-7,100
| -16% | -$189K |
|
6667
PUT
Viridian Therapeutics
VRDN
$2.81B
| $1.07M | ﹤0.01% |
47,200
+42,300
| +863% | +$692K |
|
|
GOLD
6668
PUT
Gold.com Inc
GOLD
$1.32B
| $1.07M | ﹤0.01% |
24,300
-6,000
| -20% | -$230K |
|
6669
Savers
SVV
$1.73B
| $1.07M | ﹤0.01% |
101,966
-24,006
| -19% | -$245K |
|
6670
Adaptive Biotechnologies
ADPT
$4.07B
| $1.07M | ﹤0.01% |
209,426
-192,696
| -48% | -$840K |
|
6671
CALL
Aehr Test Systems
AEHR
$3.52B
| $1.07M | ﹤0.01% |
83,300
-55,400
| -40% | -$801K |
|
6672
First Trust Dorsey Wright Momentum & Low Volatility ETF
DVOL
$73M
| $1.07M | ﹤0.01% |
32,221
+15,607
| +94% | +$495K |
|
|
SWTX
6673
PUT
DELISTED
SpringWorks Therapeutics
SWTX
| $1.07M | ﹤0.01% |
33,300
-6,600
| -17% | -$247K |
|
6674
PUT
Sasol
SSL
$7.76B
| $1.07M | ﹤0.01% |
157,700
+133,900
| +563% | +$993K |
|
6675
State Street SPDR S&P Pharmaceuticals ETF
XPH
$555M
| $1.07M | ﹤0.01% |
24,025
+23,936
| +26,894% | +$1.02M |
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.